Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Ann Thorac Surg ; 110(6): 1904-1908, 2020 12.
Article in English | MEDLINE | ID: mdl-32343950

ABSTRACT

BACKGROUND: Although cardiac surgery among renal allograft recipients is relatively safe, less is known about the impact of cardiac surgery on the functioning renal allograft. This study assessed postoperative renal failure among renal transplant recipients undergoing cardiac surgery. METHODS: The study population was identified by matching medical record numbers from the United Network for Organ Sharing Kidney Transplant Database to a cardiovascular surgery database and The Society of Thoracic Surgeons Adult Cardiac Surgery Database for the authors' institution from January 1992 through August 2018. RESULTS: One hundred seventy-nine renal transplant recipients with a functioning allograft underwent cardiac surgery a mean of 6.4 ± 5.6 years after renal transplantation. Thirty (17.6%) of the 170 patients either died or had allograft failure during the first postoperative year. Receiver-operating characteristics curve analysis using Cox regression demonstrated an optimal cutoff point for preoperative serum creatinine predicting postoperative allograft loss is 1.9 mg/dL (hazard ratio 3; 95% confidence interval, 1.5 to 6.9) with a model C statistic of 0.642. CONCLUSIONS: The current study affirms findings in the literature that cardiac surgery in renal transplant recipients carries acceptable perioperative morbidity and mortality. Renal transplant recipients who underwent cardiac surgery had a constant hazard of renal allograft loss similar to that of the general transplant population. A preoperative serum creatinine value greater than 1.9 mg/dL increases the risk for long-term renal allograft loss after cardiac surgery.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Kidney Transplantation , Postoperative Complications/epidemiology , Renal Insufficiency/epidemiology , Adult , Aged , Creatinine/blood , Female , Graft Survival , Humans , Male , Middle Aged , Predictive Value of Tests , ROC Curve , Survival Rate , Time Factors
2.
Obes Surg ; 28(5): 1454-1455, 2018 05.
Article in English | MEDLINE | ID: mdl-29541922

ABSTRACT

BACKGROUND: Despite effectively treating obesity and its comorbidities, only a fraction of the growing obese population is evaluated for bariatric surgery. Aside from barriers including resources and social support, patients report personal experience with friends and relatives suffering poor outcomes after bariatric surgery. Rates of mortality, leaks, and strictures have decreased over the past 20 years, but few instances of gross surgeon error have been reported in the literature. Our objective is to report and demonstrate the revision of a critically shortened Roux limb in a patient with chronic nausea and dysphagia found to have a 15-cm Roux limb and briefly discuss its implications. METHODS: We performed a successful laparoscopic revision of this patient's previous Roux-en-Y gastric bypass, with creation of a 125-cm Roux limb. RESULTS: Total operative time was 87 min, there were no major intraoperative complications, and the post-operative course was unremarkable. At one-month follow-up, the patient reported complete resolution of all prior symptoms. At three-month follow-up, BMI decreased from 37 prior to revision to 31. CONCLUSIONS: Reducing complications and improving quality of care will support the necessary growth of bariatric surgery. Standards set forth by accreditation bodies such as the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) assist in this endeavor, and technical errors, though difficult to evaluate, should be monitored.


Subject(s)
Gastric Bypass/adverse effects , Obesity, Morbid/surgery , Reoperation/methods , Bariatric Surgery , Female , Humans , Laparoscopy , Middle Aged , Operative Time , Quality Improvement , Weight Loss
3.
Emerg Infect Dis ; 24(3): 485-491, 2018 03.
Article in English | MEDLINE | ID: mdl-29460734

ABSTRACT

Nontuberculous mycobacteria (NTM) respiratory infections represent a growing public health problem in many countries. However, there are limited published epidemiologic studies for the Western Pacific region. We reviewed respiratory specimens submitted to Diagnostic Laboratory Services in Hawaii, USA, for culture of Mycobacterium tuberculosis during August 2007-December 2011 to determine the NTM isolation rate. We observed a statistically significant increase in the rate of specimens with NTM isolated in respiratory culture (adjusted rate ratio per year 1.65, 95% CI 1.54-1.77; p<0.01). In contrast, the number of patients with respiratory cultures positive for M. tuberculosis showed no increase (adjusted rate ratio per year 0.98, 95% CI 0.94-1.01; p = 0.19). A 6-month subset of NTM isolates was identified by using a nucleic acid probe or 16S rRNA sequencing. M. avium complex and M. fortuitum were the most common NTM identified.


Subject(s)
Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Female , Humans , Male , Mycobacterium Infections, Nontuberculous/diagnosis , Pacific Islands/epidemiology , Prevalence , Public Health Surveillance , Respiratory Tract Infections/diagnosis , United States/epidemiology
4.
J Clin Microbiol ; 51(11): 3900-2, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24006007

ABSTRACT

A 54-year-old female with a prosthetic mitral valve presented with a 3-day history of dizziness, subjective fever, and chills. Blood cultures were positive for a pleomorphic Gram-positive rod. Initial phenotypic testing could only support the identification of a Corynebacterium species. Nucleic acid sequencing (16S rRNA) and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) were conclusive for Corynebacterium diphtheriae. Definitive phenotypic testing classified the strain as nontoxigenic C. diphtheriae biotype Gravis.


Subject(s)
Corynebacterium Infections/diagnosis , Corynebacterium Infections/microbiology , Corynebacterium diphtheriae/isolation & purification , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/diagnosis , Sepsis/complications , Sepsis/diagnosis , Anti-Bacterial Agents/pharmacology , Corynebacterium diphtheriae/classification , Corynebacterium diphtheriae/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Diphtheria Toxin/genetics , Endocarditis, Bacterial/microbiology , Female , Humans , Microbial Sensitivity Tests , Middle Aged , Molecular Sequence Data , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/microbiology , RNA, Ribosomal, 16S/genetics , Risk Factors , Sepsis/microbiology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
6.
J Clin Microbiol ; 46(6): 2009-14, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18337385

ABSTRACT

Actinomyces spp. are considered rare pathogens in today's medicine, especially with thoracic vertebral involvement. Classic actinomycosis (50%) presents as an oral-cervicofacial ("lumpy jaw") infection. This report describes a case of spinal cord compression caused by Actinomyces israelii with the coisolation of Fusobacterium nucleatum. There are limited numbers of similar cases.


Subject(s)
Actinomycosis/complications , Fusobacterium Infections/complications , Spondylitis/microbiology , Thoracic Vertebrae/microbiology , Actinomyces/classification , Actinomyces/isolation & purification , Actinomycosis/microbiology , Adult , Epidural Abscess/microbiology , Fusobacterium/classification , Fusobacterium/isolation & purification , Fusobacterium Infections/microbiology , Humans , Male
7.
J Clin Microbiol ; 45(7): 2330-3, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17507517

ABSTRACT

Nocardia asteroides was isolated after prolonged culture from the pericardial fluid of a human immunodeficiency virus-infected patient. The lengthy duration required for culture growth and identification of this N. asteroides isolate affected both initial therapeutic decisions and patient management. A proposed algorithm for the microbiological workup of pericardial fluid for possible Nocardia spp. is described in an effort to improve the timeliness of results.


Subject(s)
HIV Infections/complications , Nocardia Infections/etiology , Nocardia asteroides/isolation & purification , Pericarditis/microbiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Humans , Male , Nocardia Infections/diagnosis , Nocardia Infections/pathology , Pericarditis/diagnosis , Pericarditis/pathology , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
8.
Clin Chem ; 48(7): 1028-34, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12089171

ABSTRACT

BACKGROUND: Recent guidelines for use of cardiac troponin to detect cardiac damage and for cardiovascular risk stratification have made increasingly sensitive troponin assays important. Troponin assays continue to be plagued by interferences caused by heterophilic antibodies (HAs). We evaluated the performance of a revised cardiac troponin I (cTnI) assay designed to have increased analytical sensitivity and to minimize the effect of HAs. METHODS: The revised Dade Behring Dimension cTnI assay was evaluated according to NCCLS EP5-A at five institutions. Plasma samples from 14 309 patients were assayed by the original Dimension cTnI assay. To identify samples that may have interfering HAs, samples with values >1.4 microg/L were reanalyzed on the Dade Behring Stratus CS cTnI assay. Samples with possible interfering antibodies were also analyzed before and after selective absorbance studies on the revised Dade Behring Dimension cTnI assay. RESULTS: The limit of quantification in the revised method was 0.1 microg/L with imprecision (CV) of 11-17% at 0.1 microg/L. Values correlated well with the Stratus CS cTnI method: revised = 1.06(original) + 0.01; r = 0.98, S(y/x) = 0.25 microg/L). Falsely increased results consistent with myocardial infarction by the original Dimension cTnI assay and presumably attributable to HAs were identified in 0.17% of all patients with samples submitted for cTnI analysis. The revised Dimension cTnI assay eliminated the interference in 17 of 25 samples identified and greatly decreased the interference in the other 8. CONCLUSIONS: The revised Dimension cTnI method greatly minimizes the effect of interfering HAs. It also exhibits analytical performance characteristics consistent with recent guidelines for use of this assay to detect cardiac damage.


Subject(s)
Antibodies, Heterophile/blood , Myocardium/chemistry , Troponin I/blood , Adolescent , Adult , Aged , Aged, 80 and over , Cardiovascular Diseases/diagnosis , Cross Reactions , Female , Humans , Immunoassay , Male , Middle Aged , Reference Values , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...